Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
The New England Journal of Medicine
|
November 24, 1977
Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis
P C Dau, J M Lindstrom, C K Cassel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 14, 2000
Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor
L E Spitler, M L Grossbard, M S Ernstoff, et al.
Seminars in Oncology
|
September 11, 1999
Immunologic approaches to the treatment of prostate cancer
D T Harris, G R Matyas, L G Gomella, et al.
The Journal of Clinical Investigation
|
March 1, 1975
Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor
A S Levin, V S Byers, H H Fudenberg, et al.
Investigative Radiology
|
December 1, 1986
Improved immune-specificity in monoclonal radioimmunoimaging using dual radionuclide color functional maps
B L Engelstad, E C Ramos, J Stoudemire, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
June 13, 2000
Clinical experience with autologous tumor cell lines for patient-specific vaccine therapy in metastatic melanoma
R O Dillman, S K Nayak, N M Barth, et al.
Critical Reviews in Oncology/Hematology
|
June 22, 2001
Short-term autologous tumor cell lines for the active specific immunotherapy of patients with metastatic melanoma
R O Dillman, C DeLeon, L D Beutel, et al.
The Journal of Clinical Investigation
|
December 1, 1972
The Wiskott-Aldrich syndrome. Results of transfer factor therapy
L E Spitler, A S Levin, D P Stites, et al.
Cancer Research
|
March 15, 1987
Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin
L E Spitler, M del Rio, A Khentigan, et al.
Radiology
|
November 1, 1986
Phase 1 immunolymphoscintigraphy with an In-111-labeled antimelanoma monoclonal antibody
B L Engelstad, L E Spitler, M J Del Rio, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
The New England Journal of Medicine
|
November 24, 1977
Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis
P C Dau, J M Lindstrom, C K Cassel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 14, 2000
Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor
L E Spitler, M L Grossbard, M S Ernstoff, et al.
Seminars in Oncology
|
September 11, 1999
Immunologic approaches to the treatment of prostate cancer
D T Harris, G R Matyas, L G Gomella, et al.
The Journal of Clinical Investigation
|
March 1, 1975
Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor
A S Levin, V S Byers, H H Fudenberg, et al.
Investigative Radiology
|
December 1, 1986
Improved immune-specificity in monoclonal radioimmunoimaging using dual radionuclide color functional maps
B L Engelstad, E C Ramos, J Stoudemire, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
June 13, 2000
Clinical experience with autologous tumor cell lines for patient-specific vaccine therapy in metastatic melanoma
R O Dillman, S K Nayak, N M Barth, et al.
Critical Reviews in Oncology/Hematology
|
June 22, 2001
Short-term autologous tumor cell lines for the active specific immunotherapy of patients with metastatic melanoma
R O Dillman, C DeLeon, L D Beutel, et al.
The Journal of Clinical Investigation
|
December 1, 1972
The Wiskott-Aldrich syndrome. Results of transfer factor therapy
L E Spitler, A S Levin, D P Stites, et al.
Cancer Research
|
March 15, 1987
Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin
L E Spitler, M del Rio, A Khentigan, et al.
Radiology
|
November 1, 1986
Phase 1 immunolymphoscintigraphy with an In-111-labeled antimelanoma monoclonal antibody
B L Engelstad, L E Spitler, M J Del Rio, et al.
Page
of 9